The Cancer Biomarkers Research Group (CBRG) promotes research to identify, develop, and validate biological markers for early cancer detection and cancer risk assessment. Activities include development and validation of promising cancer biomarkers, collaborative databases and informatics systems, and new technologies or the refinement of existing technologies.
Read more About the Cancer Biomarkers Research Group.
News and Events
Eliminating Underlying Liver Disease Remains Key Strategy for Liver Cancer Prevention
Date Posted: May 4, 2023
Engineering Synthetic Biomarkers for Early Detection of Cancers
Date Posted: February 9, 2022
Identifying New Biomarkers to Detect Lung Cancer Earlier
Date Posted: January 14, 2022
Could A Diabetes Diagnosis Help Detect Pancreatic Cancer Early?
Date Posted: July 7, 2021